We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
-0.65%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$10.7B
AUM Growth
-$506M
Cap. Flow
-$174M
Cap. Flow %
-1.63%
Top 10 Hldgs %
9.5%
Holding
932
New
60
Increased
296
Reduced
331
Closed
64

Sector Composition

Rank Sector Weight
1 Industrials 27.1%
2 Technology 20.67%
3 Financials 13.36%
4 Consumer Discretionary 11.61%
5 Healthcare 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BTU icon
876
Peabody Energy
BTU
$2.54B
-8,379
Closed -$203K
BXC icon
877
BlueLinx
BXC
$430M
-12,312
Closed -$1.6M
CALX icon
878
Calix
CALX
$2.24B
-45,594
Closed -$1.51M
CAR icon
879
Avis
CAR
$5.47B
-1,661
Closed -$203K
CCCC icon
880
C4 Therapeutics
CCCC
$389M
-23,604
Closed -$193K
CLPT icon
881
ClearPoint Neuro
CLPT
$424M
-29,205
Closed -$199K
CMTL icon
882
Comtech Telecommunications
CMTL
$49.7M
-634,353
Closed -$2.18M
CNM icon
883
Core & Main
CNM
$7.93B
-95,856
Closed -$5.49M
CRL icon
884
Charles River Laboratories
CRL
$11.3B
-15,592
Closed -$4.22M
CVRX icon
885
CVRx
CVRX
$131M
-114,000
Closed -$2.08M
DENN
886
DELISTED
Denny's
DENN
-1,911,618
Closed -$17.1M
DIBS icon
887
1stdibs.com
DIBS
$148M
-274,439
Closed -$1.64M
DNUT icon
888
Krispy Kreme
DNUT
$562M
-166,035
Closed -$2.53M
DRVN icon
889
Driven Brands
DRVN
$2.47B
-487,905
Closed -$7.7M
DV icon
890
DoubleVerify
DV
$1.77B
-52,500
Closed -$1.85M
ECC
891
Eagle Point Credit Company
ECC
$497M
-12,054
Closed -$122K
ESTA icon
892
Establishment Labs
ESTA
$2.71B
-15,625
Closed -$795K
FATE icon
893
Fate Therapeutics
FATE
$275M
-43,399
Closed -$319K
FTHM icon
894
Fathom Holdings
FTHM
$26.4M
-580,662
Closed -$1.16M
GPRK icon
895
GeoPark
GPRK
$609M
-25,100
Closed -$241K
INDI icon
896
indie Semiconductor
INDI
$636M
-405,000
Closed -$2.87M
KYMR icon
897
Kymera Therapeutics
KYMR
$8.66B
-7,076
Closed -$284K
LAUR icon
898
Laureate Education
LAUR
$5.38B
-50,000
Closed -$729K
LFCR icon
899
Lifecore Biomedical
LFCR
$162M
-75,610
Closed -$401K
LQDA icon
900
Liquidia Corp
LQDA
$7.72B
-24,000
Closed -$354K

Similar funds

Royce & Associates's Q2 2024 Portfolio in Review

As of Q2 2024, Royce & Associates held 932 positions worth $10.7B, down 4.5% from $11.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

Royce & Associates's Q2 2024 filing shows 60 new, 296 increased, 331 reduced and 64 closed positions. Its largest new stake was Marex Group Limited Ordinary Shares: 1,319,744 shares worth $26.4M. The largest sale was FormFactor, an estimated $30.5M.

By sector, the portfolio is most concentrated in Industrials at 27% of assets, down from 28% a quarter earlier, followed by Technology and Financials.

  • Royce & Associates's largest Q2 2024 buy was Marex Group Limited Ordinary Shares: 1,319,744 shares worth $26.4M.
  • Royce & Associates added most to Enovis in Q2 2024, an estimated $23.7M increase.
  • Royce & Associates's biggest Q2 2024 reduction was FormFactor, cutting an estimated $30.5M.
  • Royce & Associates fully exited Valley National Bancorp in Q2 2024, selling an estimated $18M.
  • Royce & Associates's ten largest holdings make up 9.5% of its $10.7B portfolio in Q2 2024.
  • Royce & Associates opened 60 new positions and closed 64 in Q2 2024.
  • Royce & Associates's portfolio value fell 4.5% quarter-over-quarter to $10.7B.

Based on Royce & Associates's 13F filing for Q2 2024, filed 13 Aug 2024.